Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gimme Care vs Medi-Weightloss

Gimme Care
Graded #23

Higher grade

vs+15
Medi-Weightloss
Graded #118

Lower grade

The verdict

Gimme Care takes it — 84.6/100 to 69.6/100.

Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGimme Care +35
89
54
Dose & formulationGimme Care +15
80
65
Clinical oversightMedi-Weightloss +3
84
87
Labs & monitoringMedi-Weightloss +8
82
90
FulfillmentGimme Care +22
87
65
Contract termsGimme Care +30
85
55
Gimme Care · left barMedi-Weightloss · right bar

The numbers

MetricGimme CareMedi-Weightloss
WeighScore84.6/10069.6/100
GradeBC
Scorecard rank#23#118
Semaglutide$130/mo$199/mo (promotional rate, brand-name)
Tirzepatide$163/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Gimme Care

Graded #23 · B

Strengths

  • $130 sema / $163 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Not the cheapest tier
  • Injection-only
  • Monitoring detail limited
Medi-Weightloss

Graded #118 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard